**Core Concept**
Ifosfamide is an **alkylating agent** used in chemotherapy, primarily for the treatment of various types of cancer, including testicular cancer, ovarian cancer, and soft tissue sarcomas. Its mechanism involves cross-linking DNA strands, thereby inhibiting DNA replication and transcription. This leads to cell death, particularly in rapidly dividing cancer cells.

**Why the Correct Answer is Right**
Since the actual options and correct answer are not provided, let's focus on a general aspect of Ifosfamide: it is known for its **nephrotoxicity** and **neurotoxicity**, among other side effects. Ifosfamide requires metabolic activation by **cytochrome P450** enzymes in the liver to form its active metabolites, which then exert their cytotoxic effects.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of Option A, we cannot directly address why it might be incorrect. However, any option suggesting Ifosfamide lacks significant side effects or does not require careful dosing and monitoring would be incorrect.
**Option B:** Similarly, without specifics, if this option downplays the drug's efficacy or its use in combination therapies, it would be misleading.
**Option C:** If this option overlooks the necessity of adequate hydration to prevent Ifosfamide-induced nephrotoxicity, it would be incorrect.
**Option D:** Any statement contradicting the established pharmacological profile of Ifosfamide, such as its classification as an alkylating agent or its activation mechanism, would be wrong.

**Clinical Pearl / High-Yield Fact**
A key point to remember about Ifosfamide is its potential to cause **hemorrhagic cystitis**, a condition that can be mitigated by the use of **mesna**, which binds to the toxic metabolites of Ifosfamide in the urine, preventing them from damaging the bladder lining.

**Correct Answer:**